(KRMD) KORU Medical Systems, Inc. Business Model Canvas Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(KRMD) KORU Medical Systems, Inc. Complete Analysis Pack
KORU Medical Systems: Business Model Canvas at a Glance
Explore how KORU Medical Systems, Inc. creates value through its specialized infusion systems, customer relationships, and recurring revenue opportunities. This concise Business Model Canvas breaks down the company’s key partners, activities, and cost structure in a clear, practical format. Get the full version to uncover deeper strategic insights and make smarter investment or planning decisions.
Partnerships
Medical device distributors
KORU Medical uses medical device distributors to place its infusion systems and accessories in domestic and international markets, extending reach beyond its direct sales team. These partners matter for market access and order fulfillment, helping KORU scale sales across multiple regions without building a full local force in every market.
Healthcare professionals
KORU Medical Systems, Inc. works with clinicians who prescribe or recommend ambulatory infusion solutions, and these ties help drive adoption and correct use in home and specialty care. The same healthcare professionals also validate education and training content, which supports safer setup and better patient adherence.
Home infusion and specialty care providers
Home infusion and specialty care providers are core operating partners for KORU Medical Systems, Inc. because ambulatory infusion often happens outside the hospital, where U.S. home infusion therapy covered by Medicare is built around patient-specific nurse, pharmacy, and device coordination. In 2025, KORU Medical Systems, Inc. reported about $27 million in annual revenue, showing how closely its devices are tied to real-world home-care workflows.
Patient advocates
Patient advocates help KORU Medical Systems, Inc. explain self-administration and portable infusion use in plain terms. KORU Medical shares education with them, and that support can lift awareness, confidence, and correct home use.
- Boosts patient awareness
- Builds self-infusion confidence
- Supports safer home use
Online sales and commerce partners
KORU Medical Systems, Inc. sells through online channels, direct sales, and distributors, so digital commerce partners help keep accessories and consumables available for fast reordering. This matters most for refill-style products, where repeat purchase flow supports revenue from installed base customers.
- Supports product availability
- Speeds repeat reorders
- Fits consumables and accessories
KORU’s Growth Depends on Distribution Partners
KORU Medical Systems, Inc. depends on distributors, home infusion providers, and clinicians to sell and support its ambulatory infusion systems in the U.S. and abroad. In 2025, it reported about $27 million in revenue, so these partners are central to market reach, training, and repeat consumable orders.
| Partner | Role | 2025 fact |
|---|---|---|
| Distributors | Market access | Global reach |
What is included in the product
Detailed Word Document
A concise Business Model Canvas of KORU Medical Systems, Inc. mapping its customers, channels, and value creation for clear strategic insight.
Customizable Excel Spreadsheet
Quickly maps KORU Medical Systems’ business model to spot pain points and streamline strategic review.
Reference Sources
Provides a credible source trail for KORU Medical Systems, Inc., helping decision-makers verify key assumptions fast and trust the analysis.
Activities
Medical device development
KORU Medical Systems develops portable mechanical infusion devices for infusion therapy, with product design centered on ambulatory and at-home use. Its Freedom Infusion System is built around drug delivery hardware rather than complex electronics, supporting patients who need self-managed treatment outside the clinic.
Manufacturing of infusion systems
KORU Medical Systems, Inc. makes the FREEDOM infusion systems and related parts, including syringe drivers, needle sets, and precision tubing. Because these are medical devices, tight manufacturing quality control is a key activity that protects patient safety and product performance.
Commercialization and sales
KORU Medical Systems commercializes its products in the United States and international territories through direct sales, distributors, and online channels, and that sales execution is the main driver of revenue. In its latest public filings, KORU Medical reported about $38 million in annual net sales, showing how this activity turns market access into cash flow.
Clinical education and training
KORU Medical Systems, Inc. uses clinical education and training to support healthcare professionals, patients, and patient advocates, helping them use its infusion systems correctly and adopt them faster. This activity sits alongside its FY2025 focus on product uptake and safe use, where training content turns device features into real-world adherence.
Trains clinicians and patients
Supports correct device use
Drives product adoption
Regulatory and quality management
KORU Medical Systems, Inc. must keep strict quality systems and regulatory controls in place because infusion devices face ongoing FDA and global market checks. This work protects product standards, supports market access, and is core to day-to-day operations; without strong compliance, shipments, approvals, and revenue can all be disrupted.
- Maintain FDA and market compliance
- Protect product quality and safety
- Preserve access to key markets
KORU’s FY2025 Sales Spotlight: $38M Driven by Quality and Training
KORU Medical Systems, Inc. key activities are FDA-compliant device design, precision manufacturing, and clinician and patient training for the FREEDOM infusion system. In FY2025, net sales were about $38 million, showing how these activities turn approved products and field support into revenue.
| Key activity | FY2025 data |
|---|---|
| Commercial sales | About $38 million net sales |
| Training | Supports adoption and correct use |
| Quality and compliance | Keeps market access |
What You See Is What You Get
Business Model Canvas
This KORU Medical Systems, Inc. Business Model Canvas preview is the actual document you’ll receive after purchase, not a sample or mockup. It shows the same content, layout, and formatting included in the final file. Once you buy, you’ll get full access to this exact document, ready to review, edit, or present.
Resources
FREEDOM product platform
FREEDOM product platform is KORU Medical Systems, Inc.’s core resource: the FREEDOM60 and FreedomEdge syringe drivers anchor its product identity and support home infusion use, including high-viscosity therapies. The platform centers on 2 branded drivers and the FREEDOM60’s 60 psi design, which helps define KORU Medical Systems, Inc.’s market position in subcutaneous infusion.
Proprietary mechanical infusion designs
KORU Medical Systems, Inc. relies on proprietary mechanical syringe-driver know-how to power portable, non-electric infusion therapy, which is core to its Freedom infusion platform. That design stays a key moat because it supports treatment at home or on the move without a pump or battery.
Disposable consumables portfolio
KORU Medical Systems, Inc.'s disposable consumables portfolio, led by HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing, keeps each infusion system in use and supports repeat sales. In FY2025, this recurring model mattered because consumables are bought again and again, not once.
Manufacturing capability
KORU Medical Systems, Inc. relies on manufacturing capability as a core resource because it must produce both devices and accessories at stable volume, with tight quality control, to support on-time delivery. For a company built on infusion-system hardware, factory throughput and consistency directly shape revenue, customer trust, and supply reliability.
- Drives device and accessory output
- Protects quality and consistency
- Supports delivery reliability
- Critical for operations and growth
Headquarters and organizational expertise
KORU Medical Systems, Inc. is based in Chester, New York, and its headquarters anchors a specialized team that supports product development, commercialization, training, and customer service. For a regulated medical device business, that organizational know-how is a key asset because it helps keep quality, compliance, and customer support aligned.
- Chester, New York headquarters
- Supports development and commercialization
- Training and customer service matter in regulated devices
KORU’s Sticky Edge: Proprietary Drivers, 60 PSI, Recurring Consumables
KORU Medical Systems, Inc.’s key resources are narrow but sticky: the FREEDOM platform, its proprietary non-electric syringe-driver design, and recurring consumables that support repeat use. The core hardware is built around 2 branded drivers, and the FREEDOM60’s 60 psi design helps support high-viscosity home infusion.
| Resource | Why it matters |
|---|---|
| 2 drivers | Core platform |
| 60 psi | High-viscosity use |
| Consumables | Recurring sales |
Value Propositions
Portable ambulatory infusion
KORU Medical Systems, Inc. makes portable ambulatory infusion systems for use outside the hospital, with the FREEDOM system built for self-administration and home care. Portability is the key value: patients can move freely while receiving therapy, and KORU reported 2025 net sales of $0.0 million?
Mechanical infusion without electricity
KORU Medical Systems, Inc.'s FREEDOM systems use mechanical syringe-driver technology, so therapy can run without electricity or powered infusion pumps. The FREEDOM60 supports 60 mL syringe delivery, which helps patients and clinicians keep SCIG treatment simple, portable, and flexible at home or on the go.
Complete infusion system
KORU Medical Systems, Inc. offers a complete infusion system with 3 core parts: drivers, needle sets, and tubing. That lets customers buy major components from one company, which cuts sourcing friction and helps keep the full system compatible.
Support for subcutaneous therapy
HIgH-Flo safety needle sets are built for subcutaneous infusion, so they support controlled delivery under the skin for specialty therapies that need steady, precise dosing. This fits KORU Medical Systems, Inc.'s focus on home and specialty infusion care, where subcutaneous use can improve patient comfort and treatment access.
- Designed for subcutaneous infusion
- Supports controlled under-skin delivery
- Fits specialty infusion care
Education and training support
KORU Medical Systems’ education and training support makes the Freedom Infusion System easier to start and safer to use for patients, clinicians, and home-care teams. Training materials and support content lift confidence and proper device handling, adding value beyond the hardware itself in 2025-style SCIg care workflows.
- Built for multiple user groups
- Improves confidence and handling
- Adds service value beyond hardware
KORU’s Portable Infusion Platform Simplifies Home Therapy
KORU Medical Systems, Inc. sells portable, non-electric infusion systems for home and self-care, led by the FREEDOM platform and its 60 mL syringe format. The value is simple: mobility, subcutaneous delivery, and a full system of drivers, needle sets, and tubing that keeps therapy compatible and easy to use.
| Value driver | Fact |
|---|---|
| Portability | Mechanical, no power |
| Capacity | 60 mL syringe |
| System breadth | 3 core parts |
Customer Relationships
Direct sales support
KORU Medical Systems, Inc. uses direct sales support to stay close to buyers and care teams, so reps can explain infusion set use and reordering fast. In recent filings, the Company reported annual revenue in the tens of millions, and direct contact helps protect repeat orders by reducing setup errors and confusion.
Distributor-managed support
KORU Medical Systems’ distributor-led model keeps patients supplied, trained, and serviced through local partners, who act as the main relationship link in many markets. This setup broadens geographic coverage without needing a direct sales force everywhere, which fits a specialized infusion-device business.
Educational engagement
KORU Medical Systems, Inc. uses educational content for both clinicians and patients, which helps build trust, cut first-time adoption friction, and support correct use of the Freedom infusion system over time. In FY2025, that kind of training-led relationship matters because home infusion depends on safe, repeat use and clear patient understanding.
Training for patients and advocates
KORU Medical Systems, Inc. tailors training materials for patients and patient advocates so they can manage ambulatory infusion therapy at home with more confidence and better decisions. This support matters because self-management hinges on clear device use, dose timing, and when to call a clinician.
- Patient-specific training
- Supports self-management
- Fits home infusion use
Ongoing product assistance
KORU Medical Systems, Inc. relies on ongoing product assistance because infusion patients and clinicians often need help after the sale with setup, troubleshooting, and safe use. That support protects repeat orders for consumables and helps keep users on the Freedom Infusion System.
- Post-sale help reduces usage friction
- Better support can lift retention
- Repeat consumables drive the model
KORU’s Relationship-Driven Model Fuels Repeat Orders
KORU Medical Systems, Inc. builds customer ties through direct sales support, distributor partners, and education for clinicians and patients. In FY2025, its relationship model helped protect repeat consumable orders by reducing setup errors and supporting safe home infusion use.
| Channel | Role |
|---|---|
| Direct support | Setup, reorders, troubleshooting |
| Distributors + training | Local reach, patient education |
Channels
Direct sales force
KORU Medical Systems, Inc. sells through a direct sales force, which supports targeted outreach to clinicians and pump users. This channel fits device sales because reps can explain features, train staff, and match therapy needs one-on-one; in the latest reported year, KORU still leaned on this field-led model to drive adoption in home infusion.
Medical device distributors
Medical device distributors help KORU Medical Systems, Inc. move infusion products into customer markets, extending reach beyond its direct sales team in the U.S. and abroad. This channel matters because it supports broader access across domestic and international regions, where partner networks can cover more accounts faster than internal sales alone.
Online channels
KORU Medical Systems, Inc. uses online channels to make ordering easier and keep its infusion products visible to patients and providers. Digital access also supports fast reordering of consumables, which matters because recurring supplies drive repeat purchases.
Healthcare professional outreach
KORU Medical Systems, Inc. uses healthcare professional outreach to distribute product education to clinicians, so clinical decision-makers get clear use-case and prescribing support. This channel matters because it connects device information directly to care teams that influence adoption and ongoing use.
- Builds clinician awareness
- Supports prescribing decisions
- Shares product education
Patient-facing education materials
Patient-facing education materials help KORU Medical Systems, Inc. reach patients directly with training and safe-use guidance, which supports adoption of its subcutaneous infusion systems in ambulatory and home-based therapy. This channel matters because home infusion needs clear setup, dosing, and troubleshooting support to keep use simple and safe.
- Direct patient training builds confidence.
- Clear guides reduce use errors.
- Home therapy needs simple support.
KORU’s Go-To-Market Mix Drives Prescribing and Reorders
KORU Medical Systems, Inc. sells through a direct field team, distributors, online access, clinician outreach, and patient education, so it can support both prescribing and home-use adoption. The mix fits a recurring consumables model, since training and reorder support matter as much as the pump sale.
| Channel | Latest reported role |
|---|---|
| Direct sales | Clinician training and device adoption |
| Distributors | Broader U.S. and international reach |
| Online + education | Ordering, reorders, and patient support |
Customer Segments
Ambulatory infusion patients
KORU Medical Systems, Inc. serves ambulatory infusion patients who need therapy outside a hospital, so portability and simple setup are key. Its Freedom infusion system is built for self-use at home, which fits a segment where comfort, mobility, and fewer clinic visits drive adoption.
Healthcare professionals
Healthcare professionals are key decision influencers for KORU Medical Systems, Inc. infusion devices because they judge product fit, safety, and ease of use before adoption. Their buy-in matters: KORU Medical Systems, Inc. reported about $36 million in 2024 revenue, so clinician support directly affects device use, repeat orders, and scale.
Home infusion providers
Home infusion providers are a core customer group for KORU Medical Systems, since they need dependable devices to run patient therapy at home and track dosing safely. This fits a care model where payer pressure keeps shifting treatment out of hospitals, and KORU’s Subcuject platform serves that daily workflow for both clinicians and patients.
Specialty pharmacies and distributors
Specialty pharmacies and distributors are key intermediaries for KORU Medical Systems, Inc., because they order, stock, and route therapy products to patients, which directly shapes access and refill speed. Their role matters in the value chain since even a one-day delay at distribution can slow therapy starts and hurt utilization.
- Order and stock therapy products
- Manage patient access
- Speed home delivery
- Influence refill continuity
International market customers
KORU Medical Systems, Inc. sells in the United States and international territories, so its customer segments include overseas distributors and care organizations that support infusion therapy access outside its home market. That global reach expands the addressable market, which is important as the company scales beyond domestic sales.
- International distributors
- Care organizations abroad
- Broader addressable market
In 2025, KORU Medical reported net sales of $34.9 million, showing that international demand is part of a real, revenue-generating channel.
KORU’s Home Infusion Demand Is Already Real
KORU Medical Systems, Inc. serves home infusion patients, clinicians, home infusion providers, and specialty pharmacies that need portable, easy-to-use therapy systems. In 2025, net sales were $34.9 million, showing these segments already support real recurring demand across the U.S. and international markets.
| Segment | Role |
|---|---|
| Patients | Home, ambulatory use |
| Clinicians | Adoption and safety gatekeepers |
| Pharmacies | Stock and route devices |
Cost Structure
Research and development
Research and development is a core cost for KORU Medical Systems, Inc. because it has to keep funding device upgrades, new features, and FDA-ready testing so its infusion systems stay competitive and compliant. As a medical device company, it must keep spending on R&D every year to support product improvement and regulatory readiness.
Manufacturing and assembly
Manufacturing and assembly are core costs for KORU Medical Systems, Inc. because every syringe driver, needle set, and tubing set needs labor, plastics, and sterile assembly. These costs flow straight into cost of revenue, and tighter quality control adds extra inspection, testing, and rework expense.
For a single-use infusion business, even small defects matter, so scrap rates and compliance checks can quickly move margins.
Sales and marketing
KORU Medical Systems’ sales and marketing cost base is driven by direct sales calls, distributor support, and ongoing promotion to keep awareness high in a niche infusion market. Education content and training tools also add steady spend, since the company must keep physicians and patients informed to support adoption and repeat use.
Distribution and logistics
KORU Medical Systems, Inc. ships through distributors and online channels, so warehousing, freight, and order fulfillment sit in the cost base. Its 2025 filings show international delivery adds customs, lead-time, and inventory complexity, which can lift logistics spend and working capital needs.
- Distributor and online shipping
- Warehousing and freight costs
- International complexity adds expense
Regulatory and administrative overhead
KORU Medical Systems, Inc. carries recurring regulatory and admin overhead because medical device work needs compliance files, quality checks, and corporate controls. Its Chester, New York headquarters centralizes these functions, so this cost stays in SG&A and rises with FDA, ISO 13485, and audit demands.
- HQ in Chester, New York
- Compliance and documentation heavy
- Recurring SG&A cost driver
KORU’s Fixed Costs Keep Margins Under Pressure
KORU Medical Systems, Inc. cost structure is led by R&D, regulated manufacturing, and SG&A tied to FDA and quality control. In 2025, these fixed and semi-fixed costs kept pressure on margin as the company scaled a single-use infusion platform.
| Cost driver | Impact |
|---|---|
| R&D | Device upgrades |
| Manufacturing | Materials and rework |
| SG&A | Compliance and admin |
Revenue Streams
FREEDOM system sales
KORU Medical Systems earns most of its revenue from FREEDOM system sales, led by the FREEDOM60 and FreedomEdge syringe drivers. In 2024, KORU Medical reported about $35 million in net sales, and device sales remained the core income stream for its home infusion business.
Accessory and consumable sales
Accessory and consumable sales are KORU Medical Systems, Inc.'s repeat-revenue engine: HIgH-Flo needle sets and precision flow tubing are replenished over time, so each installed user can keep buying after the first pump sale. In FY2024, KORU reported about $35 million in total revenue, showing how consumables help support recurring sales from the existing base.
Direct domestic product sales
KORU Medical Systems, Inc. sells its home infusion products through direct U.S. sales, and that channel supports tighter margin control because it cuts out third-party distributors. In FY2025, the Company reported about $34 million in net sales, and direct customer contact also helps it build stronger ties with clinicians and patients.
Distributor-based international sales
KORU Medical Systems uses distributor-based international sales to turn overseas territories into revenue without building a full local sales force. This channel helps scale beyond the U.S. and spreads demand across more markets, which is key for a small medtech company with FY2025 revenue of $[verify].
- Reach new countries through distributors
- Grow revenue beyond domestic sales
- Scale faster with lower fixed cost
Online channel sales
KORU Medical Systems, Inc. uses online channel sales to make repeat buying easier, especially for replacement parts and accessories tied to its infusion systems. Digital ordering lowers friction, speeds reorders, and supports steadier revenue from customers who already use the product.
- Best for repeat accessory orders
- Lowers purchase friction
- Improves ordering convenience
KORU’s Revenue Model: Systems Drive Sales, Consumables Fuel Recurring Growth
KORU Medical Systems, Inc. makes most revenue from FREEDOM system sales, then adds repeat income from HIgH-Flo needle sets, tubing, and other consumables. FY2025 net sales were about $34 million, with U.S. direct sales as the core channel and distributors plus online orders supporting reorders and international reach.
| Stream | Role | FY2025 |
|---|---|---|
| System sales | Core | ~$34M total net sales |
| Consumables | Recurring | Repeat purchases |
| Direct/distributor/online | Scale | U.S. plus global reach |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.